CTLA4 and fibrosis: Our data showed that anti‐CTLA‐4 m2a antibody‐induced cardiac dysfunction, increase in the serum cTnI levels, cardiac inflammation, and cardiac fibrosis in EAM mice were rescued by SB225002 or Cxcl1 neutralizing antibody in EAM mice (Figure6a–h).